A din­ner in Paris re­vived talks for Sanofi's $9.5B deal for Blue­print

For Blue­print Med­i­cines, a mon­u­men­tal meal in the City of Bridges helped bring back to life Sanofi’s in­ter­est in ac­quir­ing the com­mer­cial-stage drug­mak­er.

Blue­print had …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER